Pneumocystis jirovecii Pneumonia in an Infant: The Tip of the Iceberg

Gigliotti F Wright TW . Pneumocystis jirovecii. In: Long SS Prober CG Fischer M , eds. Principles and Practice of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: Elsevier; 2018:1266-1269.

Pyrgos V Shoham S Roilides E Walsh TJ. Pneumocystis pneumonia in children. Paediatr Respir Rev. 2009;10:192-198.

Ewald H Raatz H Boscacci R Furrer H Bucher HC Briel M. Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in patients with HIV infection. Cochrane Database Syst Rev. 2015;(4):CD006150.

McLaughlin GE Virdee SS Schleien CL Holzman BH Scott GB. Effect of corticosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii-related respiratory failure. J Pediatr. 1995;126(5 pt 1):821-824.

Pareja JG Garland R Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest. 1998;113:1215-1224.

Delclaux C Zahar JR Amraoui G et al . Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients. Clin Infect Dis. 1999;29:670-672.

Limper AH Offord KP Smith TF Martin WJ. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis. 1989;140:1204-1209.

Mofenson LM Brady MT Danner SP et al . Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009;58(RR-11):1-166.

Gona P Van Dyke RB Williams PL et al . Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296:292-300.

Nesheim SR Kapogiannis BG Soe MM et al . Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004. Pediatrics. 2007;120:100-109.

Saltzman RW Albin S Russo P Sullivan KE. Clinical conditions associated with PCP in children. Pediatr Pulmonol. 2012;47:510-516.

Picard C Al-Herz W Bousfiha A et al . Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35:696-726.

Kwan A Abraham RS Currier R et al . Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729-738.

Griffith LM Cowan MJ Notarangelo LD et al ; Workshop Participants. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis and management. J Allergy Clin Immunol. 2009;124:1152-1160.e12.

Shearer WT Dunn E Notarangelo LD et al . Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol. 2014;133:1092-1098.

Villa A Sobacchi C Notarangelo LD et al . V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97:81-88.

Notarangelo LD Kim MS Walter JE Lee YN. Human RAG mutations: biochemistry and clinical implications. Nat Rev Immnol. 2016;16:234-246.

Chou J Hanna-Wakim R Tirosh I et al . A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome. J Allergy Clin Immunol. 2012;130:1414-1416.

Papadopoulou-Alataki E Hassan A Davies EG. Prevention of infection in children and adolescents with primary immunodeficiency disorders. Asian Pac J Allergy Immunol. 2012;30:249-258.

Heimall J Logan BR Cowan MJ et al . Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017;130:2718-2727.

Schuetz C Neven B Dvorak CC et al . SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood. 2014;123:281-289.

Ferrua F Aiuti A. Twenty-five years of gene therapy for ADA-SCID: from bubble babies to an approved drug. Hum Gene Ther. 2017;28:972-981.